SC
ROIV icon

Shay Capital’s Roivant Sciences ROIV Stock Holding History

Shay Capital’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-15,478
Closed -$174K – 493
2025
Q2 		$174K Hold
15,478
– – 0.02% 262
2025
Q1 		$156K Hold
15,478
– – 0.02% 253
2024
Q4 		$183K Sell
15,478
-750
-5% -$8.87K 0.03% 263
2024
Q3 		$187K Sell
16,228
-2,355
-13% -$26.8K 0.03% 256
2024
Q2 		$196K Buy
18,583
+1,214
+7% +$13.3K 0.03% 221
2024
Q1 		$183K Buy
+17,369
New +$187K 0.03% 304
2023
Q2 		– Sell
-25,000
Closed -$185K – 552
2023
Q1 		$185K Buy
+25,000
New +$206K 0.04% 295

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PSC
Patient Square Capital Menlo Park, California $564M AUM 261.3% 1-Year Est. Return

Shay Capital's ROIV Position: Q3 2025 in Review

Shay Capital sold out of Roivant Sciences (ROIV) in Q3 2025, closing a stake of 15,478 shares — an estimated $174K sold.

Shay Capital first reported a position in ROIV in Q1 2023 and held it in 7 quarters. The position peaked at $196K in Q2 2024. 337 funds tracked by Wall St. Rank hold ROIV as of Q3 2025.

  • Shay Capital reported no remaining Roivant Sciences position as of Q3 2025 after selling out during the quarter.
  • Shay Capital sold 15,478 Roivant Sciences shares in Q3 2025, an estimated $174K.
  • Shay Capital first reported a position in Roivant Sciences in Q1 2023 and held it in 7 quarters.
  • Shay Capital's Roivant Sciences position peaked at $196K in Q2 2024.
  • 337 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2025.

Based on Shay Capital's 13F filing for Q3 2025, filed 14 Nov 2025.